Octarine Bio, the synthetic biology drug development company that produces psilocybin from sugar using fermentation, partners with clinical research organisation Clerkenwell Health to deliver clinical trials. – Europe’s commercial psychedelic healthcare ecosystem is growing, building on a strong heritage of academic and civil society support – A partnership between these two innovative startups…
